Morgan Stanley
AIFF

Morgan Stanley’s Firefly Neuroscience AIFF Stock Holding History

Morgan Stanley’s Portfolio AIFF Stock Details AIFF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,830
Closed -$34.5K – 8635
2026
Q1 		$34.5K Buy
+15,830
New +$19.7K ﹤0.01% 6547
2025
Q4 		– Sell
-3,529
Closed -$10.3K – 8522
2025
Q3 		$10.3K Buy
+3,529
New +$9.99K ﹤0.01% 6896
2025
Q2 		– Sell
-18,365
Closed -$72.2K – 8306
2025
Q1 		$72.2K Buy
+18,365
New +$84.5K ﹤0.01% 6151
2023
Q3 		– Sell
-117
Closed -$1.07K – 7716
2023
Q2 		$1.07K Hold
117
– – ﹤0.01% 7285
2023
Q1 		$1.02K Hold
117
– – ﹤0.01% 7352
2022
Q4 		$1.69K Hold
117
– – ﹤0.01% 7398
2022
Q3 		$3K Hold
117
– – ﹤0.01% 7405
2022
Q2 		$5K Hold
117
– – ﹤0.01% 7410
2022
Q1 		$19K Hold
117
– – ﹤0.01% 7177
2021
Q4 		$17K Buy
+117
New +$14K ﹤0.01% 7284

Other funds holding AIFF

M
Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCA
Cygnus Capital Advisors Atlanta, Georgia $147M AUM

Morgan Stanley's AIFF Position: Q2 2026 in Review

Morgan Stanley sold out of Firefly Neuroscience (AIFF) in Q2 2026, closing a stake of 15,830 shares — an estimated $34.5K sold.

Morgan Stanley first reported a position in AIFF in Q4 2021 and held it in 10 quarters. The position peaked at $72.2K in Q1 2025. 23 funds tracked by Wall St. Rank hold AIFF as of Q2 2026.

  • Morgan Stanley reported no remaining Firefly Neuroscience position as of Q2 2026 after selling out during the quarter.
  • Morgan Stanley sold 15,830 Firefly Neuroscience shares in Q2 2026, an estimated $34.5K.
  • Morgan Stanley first reported a position in Firefly Neuroscience in Q4 2021 and held it in 10 quarters.
  • Morgan Stanley's Firefly Neuroscience position peaked at $72.2K in Q1 2025.
  • 23 funds tracked by Wall St. Rank held Firefly Neuroscience as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.